Cargando…

Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort

BACKGROUND: The mortality rates of coronavirus disease 2019 (COVID-19) have been changed across the epidemiological waves. The aim was to investigate the differences in mortality rates of COVID-19 patients in Japan across the 6 epidemiological waves stratified by age group and Coronavirus Clinical C...

Descripción completa

Detalles Bibliográficos
Autores principales: Baba, Hiroaki, Ikumi, Saori, Aoyama, Shotaro, Ishikawa, Tetsuo, Asai, Yusuke, Matsunaga, Nobuaki, Ohmagari, Norio, Kanamori, Hajime, Tokuda, Koichi, Ueda, Takuya, Kawakami, Eiryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846187/
https://www.ncbi.nlm.nih.gov/pubmed/36686635
http://dx.doi.org/10.1093/ofid/ofac638
_version_ 1784871108985487360
author Baba, Hiroaki
Ikumi, Saori
Aoyama, Shotaro
Ishikawa, Tetsuo
Asai, Yusuke
Matsunaga, Nobuaki
Ohmagari, Norio
Kanamori, Hajime
Tokuda, Koichi
Ueda, Takuya
Kawakami, Eiryo
author_facet Baba, Hiroaki
Ikumi, Saori
Aoyama, Shotaro
Ishikawa, Tetsuo
Asai, Yusuke
Matsunaga, Nobuaki
Ohmagari, Norio
Kanamori, Hajime
Tokuda, Koichi
Ueda, Takuya
Kawakami, Eiryo
author_sort Baba, Hiroaki
collection PubMed
description BACKGROUND: The mortality rates of coronavirus disease 2019 (COVID-19) have been changed across the epidemiological waves. The aim was to investigate the differences in mortality rates of COVID-19 patients in Japan across the 6 epidemiological waves stratified by age group and Coronavirus Clinical Characterisation Consortium (4C) mortality score risk group. METHODS: A total of 56 986 COVID-19 patients in the COVID-19 Registry Japan from 2 March 2020 to 1 February 2022 were enrolled. These patients were categorized into 4 risk groups based on their 4C mortality score. Mortality rates of each risk group were calculated separately for different age groups: 18–64, 65–74, 75–89, and ≥90 years. In addition, mortality rates across the wave periods were calculated separately in 2 age groups: <75 and ≥75 years. All calculated mortality rates were compared with reported data from the United Kingdom (UK) during the early epidemic. RESULTS: The mortality rates of patients in Japan were significantly lower than in the UK across the board, with the exception of patients aged ≥90 years at very high risk. The mortality rates of patients aged ≥75 years at very high risk in the fourth and fifth wave periods showed no significant differences from those in the UK, whereas those in the sixth wave period were significantly lower in all age groups and in all risk groups. CONCLUSIONS: The present analysis showed that COVID-19 patients had a lower mortality rate in the most recent sixth wave period, even among patients ≥75 years old at very high risk.
format Online
Article
Text
id pubmed-9846187
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98461872023-01-20 Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort Baba, Hiroaki Ikumi, Saori Aoyama, Shotaro Ishikawa, Tetsuo Asai, Yusuke Matsunaga, Nobuaki Ohmagari, Norio Kanamori, Hajime Tokuda, Koichi Ueda, Takuya Kawakami, Eiryo Open Forum Infect Dis Major Article BACKGROUND: The mortality rates of coronavirus disease 2019 (COVID-19) have been changed across the epidemiological waves. The aim was to investigate the differences in mortality rates of COVID-19 patients in Japan across the 6 epidemiological waves stratified by age group and Coronavirus Clinical Characterisation Consortium (4C) mortality score risk group. METHODS: A total of 56 986 COVID-19 patients in the COVID-19 Registry Japan from 2 March 2020 to 1 February 2022 were enrolled. These patients were categorized into 4 risk groups based on their 4C mortality score. Mortality rates of each risk group were calculated separately for different age groups: 18–64, 65–74, 75–89, and ≥90 years. In addition, mortality rates across the wave periods were calculated separately in 2 age groups: <75 and ≥75 years. All calculated mortality rates were compared with reported data from the United Kingdom (UK) during the early epidemic. RESULTS: The mortality rates of patients in Japan were significantly lower than in the UK across the board, with the exception of patients aged ≥90 years at very high risk. The mortality rates of patients aged ≥75 years at very high risk in the fourth and fifth wave periods showed no significant differences from those in the UK, whereas those in the sixth wave period were significantly lower in all age groups and in all risk groups. CONCLUSIONS: The present analysis showed that COVID-19 patients had a lower mortality rate in the most recent sixth wave period, even among patients ≥75 years old at very high risk. Oxford University Press 2022-11-24 /pmc/articles/PMC9846187/ /pubmed/36686635 http://dx.doi.org/10.1093/ofid/ofac638 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Baba, Hiroaki
Ikumi, Saori
Aoyama, Shotaro
Ishikawa, Tetsuo
Asai, Yusuke
Matsunaga, Nobuaki
Ohmagari, Norio
Kanamori, Hajime
Tokuda, Koichi
Ueda, Takuya
Kawakami, Eiryo
Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort
title Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort
title_full Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort
title_fullStr Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort
title_full_unstemmed Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort
title_short Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 Cohort
title_sort statistical analysis of mortality rates of coronavirus disease 2019 (covid-19) patients in japan across the 4c mortality score risk groups, age groups, and epidemiological waves: a report from the nationwide covid-19 cohort
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846187/
https://www.ncbi.nlm.nih.gov/pubmed/36686635
http://dx.doi.org/10.1093/ofid/ofac638
work_keys_str_mv AT babahiroaki statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT ikumisaori statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT aoyamashotaro statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT ishikawatetsuo statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT asaiyusuke statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT matsunaganobuaki statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT ohmagarinorio statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT kanamorihajime statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT tokudakoichi statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT uedatakuya statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort
AT kawakamieiryo statisticalanalysisofmortalityratesofcoronavirusdisease2019covid19patientsinjapanacrossthe4cmortalityscoreriskgroupsagegroupsandepidemiologicalwavesareportfromthenationwidecovid19cohort